Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine tartrate for Plegridy injection-related erythema
NL-OMON42363Phase 4Active, not recruiting
- Sponsor
- Biogen
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of brimonidine, sponsored by Biogen. Started Oct 2015; status: active, not recruiting.
02
Drugs
brimonidine
Beyond the preview
Go deeper on NL-OMON42363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42363.